Suppliers / Cooper Sa Pharmaceuticals

Cooper Sa Pharmaceuticals

Greece 2 duplicate records merged Updated 9 July 2026

Cooper Sa Pharmaceuticals is a finished-dose manufacturer based in Greece. It appears in 81 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA and EFDA (ET). Its GMP standing is certified by EMA. Customs aggregates show $397K of exports covering 178 molecules to 7 destinations in 2025.

0
active US DMFs
0
valid CEPs
1
registered plants
81
filings across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Athens, Greece Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 75 1
EFDA (ET) 6 None

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $438K 10
2025 Not reported $397K 7

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Cooper Sa Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts